OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

Leave a Comment

Your email address will not be published. Required fields are marked *

Chatbot Avatar
Chatbot Avatar
Chat with us! AI assistant
Chatbot Avatar

Hello! How can I help you today?

error: Content is protected !!
Scroll to Top